Retinoic acid Receptors (RARs)

Retinoic acid receptor alpha, beta, and gamma are ligand-activated nuclear receptors that function as transcription factors, modulating gene expression in response to endogenous and exogenous retinoids (forms of vitamin A). Each receptor type, encoded by separate genes (RARA, RARB, RARG), heterodimerizes with retinoid X receptors (RXRs) to bind specific DNA sequences and regulate a wide range of developmental, differentiation, and homeostatic processes. These receptors play non-redundant roles in embryogenesis, organ development, skin homeostasis, and tumorigenesis. Clinically, they are major therapeutic targets in dermatology (for acne, psoriasis, photoaging, pigment disorders) and oncology (notably, RARA in acute promyelocytic leukemia treated with all-trans retinoic acid). This entry is flagged as 'incorrect' because the initial target list provided 'Retinoic acid receptor beta 2', which is a specific isoform or splice variant of RAR-beta, rather than the more general and canonical 'Retinoic acid receptor beta'. The proper canonical forms are 'Retinoic acid receptor alpha,' 'Retinoic acid receptor beta,' and 'Retinoic acid receptor gamma.' Additionally, listing all three highly homologous but distinct receptors (alpha, beta, gamma) within a single entry, while representing the 'Retinoic acid Receptors' family, may combine related but distinct targets, which ideally would be represented as separate canonical entries for precision. Nevertheless, the RARs as a family are clear and widely used therapeutic targets, especially in dermatology and oncology.

Other names

NR1B1 (RAR-alpha)NR1B2 (RAR-beta)NR1B3 (RAR-gamma)Retinoic acid receptors (collective)RARARARBRARG

Ligand-activated transcription factor: retinoids bind to RARs, forming RAR/RXR heterodimers that bind DNA at retinoic acid response elements to modulate transcription of target genes. Corepressor–coactivator switching: ligand binding shifts RARs from a transcriptionally repressive to an active state. Modulation of cell differentiation and proliferation pathways.